Latest Insider Transactions at Frequency Therapeutics, Inc. (FREQ)
This section provides a real-time view of insider transactions for Frequency Therapeutics, Inc. (FREQ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Frequency Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Frequency Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,347
-8.56%
|
$5,388
$4.33 P/Share
|
|
Feb 15
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
863
-2.19%
|
$3,452
$4.33 P/Share
|
|
Feb 15
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,261
-4.27%
|
$5,044
$4.33 P/Share
|
|
Feb 15
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
844
-5.36%
|
$3,376
$4.33 P/Share
|
|
Feb 14
2022
|
Wendy S Arnold Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.87%
|
-
|
|
Feb 14
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.79%
|
-
|
|
Feb 14
2022
|
Christopher R. Loose Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.53%
|
-
|
|
Feb 14
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+37.18%
|
-
|
|
Feb 14
2022
|
Carl Le Bel Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.79%
|
-
|
|
Jan 18
2022
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.45%
|
$0
$0.61 P/Share
|
|
Dec 20
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.47%
|
$0
$0.61 P/Share
|
|
Nov 02
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.49%
|
$0
$0.61 P/Share
|
|
Oct 05
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.51%
|
$0
$0.61 P/Share
|
|
Sep 03
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.54%
|
$0
$0.61 P/Share
|
|
Aug 03
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.56%
|
$0
$0.61 P/Share
|
|
Jul 01
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.59%
|
$0
$0.61 P/Share
|
|
Jun 21
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
113,690
+21.23%
|
$0
$0.61 P/Share
|
|
May 17
2021
|
Quentin Mc Cubbin Chief Manufacturing Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$80,000
$8.85 P/Share
|
|
Mar 25
2021
|
Joel S Marcus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,116
+10.78%
|
$111,348
$3.37 P/Share
|
|
Mar 01
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
9,416
-0.6%
|
$470,800
$50.11 P/Share
|
|
Mar 01
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
9,416
+2.88%
|
$0
$0.61 P/Share
|
|
Feb 08
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
16,554
-1.73%
|
$910,470
$55.0 P/Share
|
|
Feb 08
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
16,554
+4.85%
|
$0
$0.61 P/Share
|
|
Feb 03
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
11,036
-1.74%
|
$529,728
$48.75 P/Share
|
|
Feb 03
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
11,036
+3.34%
|
$0
$0.61 P/Share
|
|
Feb 03
2021
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.41%
|
$94,000
$47.19 P/Share
|
|
Feb 02
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
5,518
-0.59%
|
$253,828
$46.65 P/Share
|
|
Feb 02
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
5,518
+1.73%
|
$0
$0.61 P/Share
|
|
Feb 02
2021
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-25.17%
|
$360,000
$45.02 P/Share
|
|
Feb 01
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
33,102
-2.5%
|
$1,423,386
$43.11 P/Share
|
|
Feb 01
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
33,102
+8.84%
|
$0
$0.61 P/Share
|
|
Jan 27
2021
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-20.11%
|
$336,000
$42.5 P/Share
|
|
Jan 27
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
9,196
-2.9%
|
$386,232
$42.5 P/Share
|
|
Jan 27
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
9,196
+2.82%
|
$0
$0.61 P/Share
|
|
Jan 06
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
27,586
-1.69%
|
$1,048,268
$38.24 P/Share
|
|
Jan 06
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
27,586
+7.59%
|
$0
$0.61 P/Share
|
|
Jan 04
2021
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
34,104
-3.4%
|
$1,159,536
$34.05 P/Share
|
|
Jan 04
2021
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
18,390
+2.62%
|
$0
$0.61 P/Share
|
|
Dec 22
2020
|
Joel S Marcus Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.76%
|
$660,000
$33.29 P/Share
|
|
Dec 21
2020
|
Joel S Marcus Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.33%
|
$300,000
$30.35 P/Share
|
|
Dec 18
2020
|
Joel S Marcus Director |
SELL
Open market or private sale
|
Direct |
19,700
-1.26%
|
$709,200
$36.07 P/Share
|
|
Dec 17
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
1,120
-0.34%
|
$47,040
$42.64 P/Share
|
|
Dec 17
2020
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
1,120
+0.34%
|
$0
$0.61 P/Share
|
|
Dec 17
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-8.67%
|
$328,000
$41.25 P/Share
|
|
Dec 16
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-7.45%
|
$304,000
$38.93 P/Share
|
|
Dec 16
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
13,514
-4.01%
|
$540,560
$40.0 P/Share
|
|
Dec 16
2020
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
13,514
+3.85%
|
$0
$0.61 P/Share
|
|
Dec 15
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-12.54%
|
$296,000
$37.28 P/Share
|
|
Dec 15
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
13,514
-2.02%
|
$513,532
$38.51 P/Share
|
|
Dec 15
2020
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
13,514
+1.98%
|
$0
$0.61 P/Share
|